MetaCap

Sagimet Biosciences Series A Statistics

NASDAQ: SGMTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

9.08-0.54 (-5.61%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Sagimet Biosciences Series A by the numbers

Sagimet Biosciences Series A has a market capitalization of $648.0 million based on 71.37M shares outstanding. With trailing EPS of $-1.18, Sagimet Biosciences Series A is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.0% below its 50-day average and 16.4% above its 200-day average.

Average daily trading volume is 1.23M shares, or about $11.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

SGMT valuation vs. peer median

SGMT compared with the median of 8 peer companies
MetricSGMTPeer medianDifference
Market cap$648.02M$625.81M+4%
Avg. volume1.23M1.69M-27%

Peer median across 8 companies: KURA, NVCT, APMD, JANX, ABUS, OLMA, LXRX, ANNX.

Valuation

Price and trading

Previous close
9.62
Open
9.32
Day range
8.83 – 9.40
52-week range
4.50 – 11.45
52-week change
+36.13%
Beta
—
Volume
1.50M

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
648.02M
Forward Pe
-6.40
Eps
-1.18
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
11.45
Week52 Low
4.50
Avg Volume
1.23M
Shares Outstanding
71.37M
Ma50
9.77
Ma200
7.80
Earnings Date
Nov 12, 2026
Pct From52w High
-20.69%
Pct From52w Low
101.78%

Related